NCT07114653Recruiting
The Role of POLE Mutation in High Risk Endometrial Cancer.
Source: ClinicalTrials.gov · Last updated 11 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is: What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 4 Aug 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Far Eastern Memorial Hospital
- Diseases
- Endometrial cancer, Childhood cancers
- NCT number
- NCT07114653
What you commit to
- Study type: Observational
- Planned participants: 150
- From 1 Sept 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Nil
Who the study is looking for
- women with high-risk for recurrent endometrial cancer
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital Coordinator of this site? Confirm its status | Banqiao District | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.